Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Stevanato Group, often referred to simply as Stevanato, is a leading provider of integrated solutions for the pharmaceutical and biotechnology industries. Headquartered in Italy, the company operates extensively across Europe, North America, and Asia, delivering innovative products and services that enhance drug delivery systems. Founded in 1949, Stevanato has achieved significant milestones, including advancements in glass primary packaging and the development of cutting-edge automation technologies.
The company’s core offerings include glass vials, syringes, and advanced drug delivery systems, distinguished by their high quality and reliability. Stevanato's commitment to innovation has solidified its position as a trusted partner for global pharmaceutical companies, contributing to the safe and effective delivery of medications. With a strong market presence and a reputation for excellence, Stevanato continues to shape the future of pharmaceutical packaging and delivery solutions.
+16 vs industry average
Stevanato’s score of 58 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
In 2025, Stevanato Group reported total carbon emissions of approximately 769.6 million kg CO2e. This figure includes Scope 1 emissions of about 54.7 million kg CO2e, Scope 2 emissions of approximately 35.4 million kg CO2e, and significant Scope 3 emissions totalling around 679.6 million kg CO2e. The company has demonstrated a commitment to reducing its greenhouse gas emissions, with a target to achieve net zero by 2050. This commitment includes setting science-based targets and aims for reductions within the next five to ten years.
Stevanato Group's emissions data is cascaded from its parent company, Stevanato Group S.p.A., which provides a comprehensive overview of its climate impact. The company is actively working towards its climate goals within the healthcare equipment and supplies sector, based in Italy.
Overall, Stevanato Group's climate strategy reflects a proactive approach to sustainability, aligning with industry standards and addressing the urgent need for emissions reductions.
2035
65% reduction in Scope 2
STV commits to reduce absolute scope 2 GHG emissions 65.0% by 2035 from a 2023 base year.
2035
65% reduction in Scope 1
STV commits to reduce absolute scope 1 GHG emissions 65.0% by 2035 from a 2023 base year.
2035
67% reduction in scope 3 total
STV also commits to reduce scope 3 GHG emissions 67.0% per USD value added within the same timeframe.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Stevanato’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more